MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer

ConclusionTaken together, miR-143-3p and miR-495-3p co-target CDK1, thereby inhibiting the occurrence and development of cervical cancer.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research